References
- UdvardyAGyulaiZSiposAExtensive study of the autooxidation products of apomorphine and its pharmacologically active derivativesJ Mol Struct201110021–33744
- ShabirGAStep-by-step analytical methods validation and protocol in the quality system compliance industryJ Valid Technol200510314325
- GieseckeJThe absolute configuration of apomorphineActa Cryst1977B33302303
- SubramonyJAApomorphine in dopaminergic therapyMol Pharm20063438038516889431
- GarridoJMDelerue-MatosCBorgesFMacedoTROliveira-BrettAMNew insights into the oxidation pathways of apomorphineJ Chem Soc20021017131717
- BurkmanAMSome kinetic and thermodynamic characteristics of apomorphine degradationJ Pharm Sci19655432532614293833
- Ng Ying KinNMLalSThavundayilJXStability of apomorphine hydrochloride in aqueous sodium bisulphite solutionsProg Neuropsychopharmacol Biol Psychiatry20012571461146811513359
- DeckerWJCorbyDGCombsHFA stable parenteral solution of apomorphineClin Toxicol19811877637727307461
- WilcoxREHumphreyDWRiffeeWHSmithRVStability of apomorphine in solutions containing ascorbic acid and bisulfite and effects of antioxidants on apomorphine-induced cage climbing and hypothermia in miceJ Pharm Sci19806989749767400950
- AbarcaBBallesterosRBielsaPOpposite vascular activity of (R)-apomorphine and its oxidised derivatives. Endothelium-dependent vasoconstriction induced by the auto-oxidation metaboliteEur J Med Chem200338550151112767600
- PristonMJSewellGJNovel liquid chromatographic assay for the low-level determination of apomorphine in plasmaJ Chromatogr B Biomed Appl199668111611678798925
- IngramWMPristonMJSewellGJImproved assay for R(−)-apomorphine with application to clinical pharmacokinetic studies in Parkinson’s diseaseJ Chromatogr B Analyt Technol Biomed Life Sci20068311–217
- SnyderLRKirklandJJDolanJWIntroduction to Modern Liquid ChromatographyNew JerseyJohn Wiley & Sons2011
- ShrivastavaSGuptaVMethods for the determination of limit of detection and limit of quantitation of the analytical methodsChronicles of Young Scientists2011212125
- ChatrabhujiPPandyaCPatelMHPLC Method for Determination of APIs in Pharmaceutical FormulationUSALulu Press, Inc2015
- BouwmanYLe BrunPPractical Pharmaceutics: An International Guideline for the Preparation, Care and Use of Medicinal ProductsUnited KingdomSpringer2015
- KurataTSakuraiYDegradation of L-ascorbic acid and mechanism of nonenzymic browning reaction: Part II. Non-oxidative degradation of L-ascorbic acid including the formation of 3-deoxy-L-pentosone Part III. Oxidative degradation of L-ascorbic acid (degradation of dehydro-L-ascorbic acid)Agric Biol Chem1967312170184
- PristonMSewellGThe analysis of apomorphine formulations for ambulatory infusionsPharm Pharmacol Commun1995129194
- ButlerIBSchoonenMARickardDTRemoval of dissolved oxygen from water: a comparison of four common techniquesTalanta199441221121518965910
- DegenhardtOSWatersBRebelo-CameiraoAMeyerABrunnerHToltlNPComparison of the effectiveness of various deaeration techniquesDissolut Technol2004111612